Recap: iRadimed Q3 Earnings - iRadimed (NASDAQ:IRMD)

iRadimed IRMD reported its Q3 earnings results on Thursday, November 3, 2022 at 07:00 AM.

Here's what investors need to know about the announcement.

iRadimed beat estimated earnings by 20.83%, reporting an EPS of $0.29 versus an estimate of $0.24.

Revenue was up $2.50 million from the same period last year.

Last quarter the company beat on EPS by $0.03 which was followed by a 6.88% increase in the share price the next day.

Here's a look at iRadimed's past performance:

Quarter	Q2 2022	Q1 2022	Q4 2021	Q3 2021
EPS Estimate	0.23	0.20	0.21	0.17
EPS Actual	0.26	0.22	0.33	0.23
Revenue Estimate	12.60M	12.21M	11.63M	10.40M
Revenue Actual	12.72M	12.31M	11.87M	10.91M

To track all earnings releases for iRadimed visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.